Interpretation and the Pervasiveness of Appellate Fact-Finding

On Monday, the Supreme Court granted certiorari in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (No. 13-854), which asks whether a district court’s factual findings in interpreting a patent claim are reviewed de novo or for clear error on appeal.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.